NEAT1 and prostate cancer: RNA-fluorescent ISH analysis of benign and advanced prostate tumours, including CRPC and NEPC tumour tissue samples, illustrated significantly upregulated NEAT1 levels in advanced prostate cancer, with enhanced focal staining throughout the tumour tissue (Fig. 7e).